Sovato Secures $41M Series B Funding to Advance Remote Robotic Surgery

Why It Matters

The infusion positions Sovato to scale the nascent telesurgery market, potentially expanding access to advanced surgical care while attracting further industry partnerships and validation. It underscores growing investor confidence in remote‑surgery technology as a transformative health‑care solution.

Deal Summary

Sovato announced the close of its Series B round, raising $41 million to expand its remote robotic surgery platform. Growth‑stage VC firm Beringea led the round, with participation from Polaris Partners, Intuitive, GS Ventures, Laerdal Million Lives Fund, Puma Venture Capital, Teladoc Health and other investors. The capital will accelerate product development and strategic partnerships in the telesurgery space.